Raise by Fusion42
Fusion42 Scout Wire
Capital Reports
Who's InvestingWeekly · Mon 08:00 UTCCapital UnlockedBi-weekly · Wed 08:00 UTC
Benchmarks
Benchmarks HomeFundsRoundsSectors
AI VC IndexCapital FlowAbout

Switch product

Fusion42RaiseScoutWire

Capital Reports

All editionsWho's InvestingWeekly · Mon 08:00 UTCCapital UnlockedBi-weekly · Wed 08:00 UTC

Database & benchmarks

Benchmarks HomeFundsRoundsSectorsStagesAI VC IndexCapital Flow Index

Account

Sign in
← Back

UTokyo Innovation Platform Co., Ltd. | ASA Fund

vc$495.7MCo-invests

◆ Fund Size

$495.7M

◆ Location

Japan

◆ Portfolio

698 companies

◆ Activity

Statusactively investing

◆ Links

Website ↗@utokyo_ipc on X ↗

◆ Share this fund

ShareXLinkedInEmail

◆ Investment Thesis

A Fund-of-Funds established to accelerate the growth of Japan’s deep-tech ecosystem originating from universities and research institutions by providing capital to university-affiliated VC funds.

◆ About UTokyo Innovation Platform Co., Ltd.

The ASA Fund is a Fund-of-Funds (FoF) established by the Tokyo Metropolitan Government and operated by UTokyo Innovation Platform Co., Ltd. It invests in university-affiliated VC funds that support deep-tech startups originating from academic research and universities across Japan and internationally. The fund aims to foster commercialization of high-potential technologies and strengthen Japan's innovation ecosystem.

◆ Sectors

Drug DiscoveryBiotechSemiconductorsSpace Tech

◆ Stages

growthseedseries-a

◆ Geography Focus

Japan

◆ Team

NameTitleRoleLinks
Ai GotoManager（Corporate Planning）Manager
Akihiko AsamiPartnerPartner
Akiko TsuchiyaDirector, Public RelationsDirector
Atsuhiro BingoPrincipal (Investment)Principal
Ayako FujitaManager (1stRound)Manager
Junji Takaoka (Kevin)Incubation PartnerPartner
Kazuhiko KakehiPartnerPartner
Kent SugaManager（Startup Building Program）Manager
Kosuke UedaPresident and CEOCEO
Makoto (Mark) Ohori, Ph.DPartner (Chief Investment Officer, Life Science)Partner
Masafumi KawaiPartner（CIO）Partner
Nagi HamanakaManager (Corporate Management）Manager
Nako KawashimaPrincipalPrincipal
Saori OzawaPartner（Head of Partnerships）Partner
Satoko YasudaManager (Corporate Management)Manager
Shomen IkuManagerManager
Suguru MimaPartner (Capitalist)Partner
Taiki HinoManagerManager
Takashi Chris FurukawaManaging PartnerManaging Partner
Takayuki KuwaePartnerPartner
Yuki TomokageDirector (Corporate Management)Director
Yuko HagiwaraHR DirectorDirector

◆ Notable Investments

Red 1 HealthcareHIC Fund ICREWT Medical Systems, Inc.TagCyx Biotechnologies, Inc.Braizon Therapeutics, Inc.Modalis Therapeutics CorporationAlivexis, Inc.Adriakaim Inc.FIMECS, Inc.RIN Institute Inc.LiberoThera, Company LimitedHeartseed Inc.Vertero Therapeutics, Inc.MED MIRAI, Inc.GRA&GREEN Inc.STORM Therapeutics LtdChordia Therapeutics Inc.DEM BioPhrma, Inc.reverSASP Therapeutics Co., Ltd.Carbon Biosciences, Inc.

◆ Traits

Leads rounds

Co-invests

◆ FAQ

What does ASA Fund invest in?

ASA Fund invests in Drug Discovery, Biotech, Semiconductors and Space Tech at the growth, seed and series-a stages.

Which geographies does ASA Fund focus on?

ASA Fund focuses on Japan, and is headquartered in Japan.